Towards the Optimal Screening Collection: A Synthesis Strategy
The development of effective small-molecule probes and drugs entails at least three stages: 1) a discovery phase, often requiring the synthesis and screening of candidate compounds, 2) an optimization phase, requiring the synthesis and analysis of structural variants, 3) and a manufacturing phase, r...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 47; no. 1; pp. 48 - 56 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley-VCH Verlag
2008
WILEY-VCH Verlag WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
ISSN | 1433-7851 1521-3773 1521-3773 |
DOI | 10.1002/anie.200703073 |
Cover
Summary: | The development of effective small-molecule probes and drugs entails at least three stages: 1) a discovery phase, often requiring the synthesis and screening of candidate compounds, 2) an optimization phase, requiring the synthesis and analysis of structural variants, 3) and a manufacturing phase, requiring the efficient, large-scale synthesis of the optimized probe or drug. Specialized project groups tend to undertake the individual activities without prior coordination; for example, contracted (outsourced) chemists may perform the first activity while in-house medicinal and process chemists perform the second and third development stages, respectively. The coordinated planning of these activities in advance of the first small-molecule screen tends not to be undertaken, and each project group can encounter a bottleneck that could, in principle, have been avoided with advance planning. Therefore, a challenge for synthetic chemistry is to develop a new kind of chemistry that yields a screening collection comprising small molecules that increase the probability of success in all three phases. Although this transformative chemistry remains elusive, progress is being made. Herein, we review a newly emerging strategy in diversity-oriented small-molecule synthesis that may have the potential to achieve these challenging goals. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/anie.200703073 ark:/67375/WNG-KQ3LP1MC-6 ArticleID:ANIE200703073 istex:9BDB6CA55B47616AEF44C83898CC301B88111D1B The NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD) enabled this research. T.E.N. is grateful to the Alfred Benzon Foundation for a postdoctoral research scholarship. S.L.S. is an investigator with the Howard Hughes Medical Institute. The NIGMS‐sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD) enabled this research. T.E.N. is grateful to the Alfred Benzon Foundation for a postdoctoral research scholarship. S.L.S. is an investigator with the Howard Hughes Medical Institute. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-3 |
ISSN: | 1433-7851 1521-3773 1521-3773 |
DOI: | 10.1002/anie.200703073 |